TY - JOUR
T1 - The scavenger receptor class B type I adaptor protein PDZK1 maintains endothelial monolayer integrity
AU - Zhu, Weifei
AU - Saddar, Sonika
AU - Seetharam, Divya
AU - Chambliss, Ken L.
AU - Longoria, Christopher
AU - Silver, David L.
AU - Yuhanna, Ivan S.
AU - Shaul, Philip W.
AU - Mineo, Chieko
PY - 2008/2
Y1 - 2008/2
N2 - Circulating levels of high-density lipoprotein (HDL) cholesterol are inversely related to the risk of cardiovascular disease, and HDL and the HDL receptor scavenger receptor class B type I (SR-BI) initiate signaling in endothelium through src that promotes endothelial NO synthase activity and cell migration. Such signaling requires the C-terminal PDZ-interacting domain of SR-BI. Here we show that the PDZ domain-containing protein PDZK1 is expressed in endothelium and required for HDL activation of endothelial NO synthase and cell migration; in contrast, endothelial cell responses to other stimuli, including vascular endothelial growth factor, are PDZK1-independent. Coimmunoprecipitation experiments reveal that Src interacts with SR-BI, and this process is PDZK1-independent. PDZK1 also does not regulate SR-BI abundance or plasma membrane localization in endothelium or HDL binding or cholesterol efflux. Alternatively, PDZK1 is required for HDL/SR-BI to induce Src phosphorylation. Paralleling the in vitro findings, carotid artery reendothelialization following perivascular electric injury is absent in PDZK1 mice, and this phenotype persists in PDZK1 mice with genetic reconstitution of PDZK1 expression in liver, where PDZK1 modifies SR-BI abundance. Thus, PDZK1 is uniquely required for HDL/SR-BI signaling in endothelium, and through these mechanisms, it is critically involved in the maintenance of endothelial monolayer integrity.
AB - Circulating levels of high-density lipoprotein (HDL) cholesterol are inversely related to the risk of cardiovascular disease, and HDL and the HDL receptor scavenger receptor class B type I (SR-BI) initiate signaling in endothelium through src that promotes endothelial NO synthase activity and cell migration. Such signaling requires the C-terminal PDZ-interacting domain of SR-BI. Here we show that the PDZ domain-containing protein PDZK1 is expressed in endothelium and required for HDL activation of endothelial NO synthase and cell migration; in contrast, endothelial cell responses to other stimuli, including vascular endothelial growth factor, are PDZK1-independent. Coimmunoprecipitation experiments reveal that Src interacts with SR-BI, and this process is PDZK1-independent. PDZK1 also does not regulate SR-BI abundance or plasma membrane localization in endothelium or HDL binding or cholesterol efflux. Alternatively, PDZK1 is required for HDL/SR-BI to induce Src phosphorylation. Paralleling the in vitro findings, carotid artery reendothelialization following perivascular electric injury is absent in PDZK1 mice, and this phenotype persists in PDZK1 mice with genetic reconstitution of PDZK1 expression in liver, where PDZK1 modifies SR-BI abundance. Thus, PDZK1 is uniquely required for HDL/SR-BI signaling in endothelium, and through these mechanisms, it is critically involved in the maintenance of endothelial monolayer integrity.
KW - Endothelium
KW - High-density lipoprotein
KW - PDZK1
KW - SR-BI
UR - http://www.scopus.com/inward/record.url?scp=41949142738&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=41949142738&partnerID=8YFLogxK
U2 - 10.1161/CIRCRESAHA.107.159079
DO - 10.1161/CIRCRESAHA.107.159079
M3 - Article
C2 - 18174467
AN - SCOPUS:41949142738
SN - 0009-7330
VL - 102
SP - 480
EP - 487
JO - Circulation research
JF - Circulation research
IS - 4
ER -